Allegion (ALLE) Q4 2025 earnings review
M&A and Non-Res Power Growth, But Residential Cracks Widen
Allegion closed FY25 with a solid beat, delivering 9.3% reported revenue growth and raising the dividend. However, the composition of growth is shifting. While Americas Non-Residential remains a powerhouse (+High-Single Digits), the Residential business deteriorated to a High-Single Digit decline (worse than prior quarters). Crucially, organic growth decelerated to 3.3% from 5.9% in Q3, with M&A now carrying a heavier load (+4.4% impact). International markets slid back into organic contraction (-2.3%). Management's initial 2026 guidance projects stable growth, relying on the M&A playbook and Non-Res resilience to offset consumer weakness.
🐂 Bull Case
Americas Non-Residential grew High-Single Digits organically, proving resilient against macro headwinds. This segment continues to be the primary profit engine, offsetting weakness elsewhere.
Acquisitions contributed 4.4% to Q4 growth and 3.1% to full-year growth. Management successfully integrated these assets, helping drive International margins up 90bps despite volume declines.
🐻 Bear Case
Americas Residential worsened from 'Mid-Single Digit' declines in H1 to a 'High-Single Digit' decline in Q4. High interest rates are choking renovation and new construction demand.
International organic sales fell 2.3% due to lower volumes. Without the 16% boost from acquisitions/divestitures, this segment would be shrinking significantly.
⚖️ Verdict: 🟢
Solid. Despite the residential drag, Allegion is effectively using its balance sheet (M&A) and pricing power to deliver earnings growth. The 2026 outlook suggests stability, though reliance on inorganic growth is increasing.
Key Themes
Americas Non-Residential Strength
This segment remains the company's bedrock. It posted High-Single Digit organic growth in Q4, driven by both price and volume. This consistency (growing MSD to HSD throughout 2025) validates management's 'institutional resilience' thesis against a choppy macro backdrop.
Residential Weakness Accelerating
The narrative has shifted from stabilization to deterioration. In Q1/Q2, Americas Residential was down 'Mid-Single Digits.' In Q4, this worsened to 'High-Single Digits.' This suggests that rate pressures are biting harder, or the hoped-for recovery is being pushed further out.
Americas Margin Compression
Despite strong pricing and non-residential volume, Americas Adjusted Operating Margin compressed 30 basis points to 27.1%. Management cited inflation and investment exceeding productivity gains. This breaks the trend of margin expansion seen earlier in the year.
International Organic Volatility
Reversing. After a brief return to growth in Q3 (+3.6%), International organic revenue fell 2.3% in Q4. Volume declines are persisting in global markets, forcing the segment to rely heavily on M&A (which added 16% to reported revenue) to show top-line progress.
M&A Strategy Delivering
Acquisitions are no longer just 'bolt-ons' but primary growth drivers. Reported revenue (+9.3%) far outpaced organic (+3.3%) due to a 4.4% net M&A benefit. The International segment's reported growth of 21.5% was almost entirely inorganic.
Price vs. Volume Mix
Organic growth of 3.3% was 'driven by price realization partially offset by volume declines.' This indicates that underlying unit demand remains negative across the consolidated enterprise, with pricing doing the heavy lifting to maintain growth.
Other KPIs
Up 8.1% YoY. While solid, growth decelerated in Q4 (+4.3%) compared to the full-year pace, reflecting the margin pressure in the Americas segment.
Accelerating. Up 17.6% YoY. Cash conversion remains a highlight, fueling the dividend increase and continued M&A activity.
Stable. Up 30bps YoY. Strength in International (+90bps) and Corporate cost control offset the surprising dip in the core Americas margin (-30bps).
Guidance
Decelerating. The midpoint (6.0%) is below FY25's 7.8% growth. Implies continued reliance on M&A contribution.
Stable/Decelerating. The midpoint (3.0%) represents a slowdown from FY25's 4.1% and Q4's 3.3%, signaling caution on end-market recovery.
Stable. Midpoint ($8.80) implies ~8% growth, consistent with the 8.1% growth delivered in FY25. Suggests margin expansion or buybacks will aid the bottom line despite slower top-line growth.
Key Questions
Americas Margin Compression
Americas margins compressed 30bps in Q4 despite strong pricing. Was this purely mix shift toward lower-margin non-residential projects, or are we seeing sticky cost inflation that pricing can no longer fully offset?
Residential Bottom
Residential declines worsened to High-Single Digits in Q4. Do you see a floor forming in 1H 2026, or does the FY26 guidance assume this level of deterioration continues?
International Volume
International organic growth flipped negative again in Q4 (-2.3%) driven by volume. At what point do you expect European/Global volumes to stabilize, or is the 2026 plan primarily M&A-driven for this segment?